Page last updated: 2024-09-04

docetaxel anhydrous and Blood Loss, Surgical

docetaxel anhydrous has been researched along with Blood Loss, Surgical in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, LF; Ji, ZH; Li, XB; Li, Y; Lin, YL; Ma, R; Yan, FC; Yang, ZR; Zhang, J	1
Chen, WM; Liu, EL; Mi, RR; Wang, DH; Wang, LQ; Zhang, YM	1

Trials

1 trial(s) available for docetaxel anhydrous and Blood Loss, Surgical

Article	Year
Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites. European journal of gynaecological oncology, 2017, Volume: 38, Issue:2 Topics: Administration, Intravenous; Aged; Alzheimer Disease; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Parenteral; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Operative Time; Ovarian Neoplasms; Survival Rate; Taxoids	2017

Article

Year

Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites.

European journal of gynaecological oncology, 2017, Volume: 38, Issue:2

Topics: Administration, Intravenous; Aged; Alzheimer Disease; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Parenteral; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Operative Time; Ovarian Neoplasms; Survival Rate; Taxoids

2017

Other Studies

1 other study(ies) available for docetaxel anhydrous and Blood Loss, Surgical

Article	Year
Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:4 Pt A Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult	2020

Article

Year

Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:4 Pt A

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Blood Loss, Surgical; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Erythrocyte Transfusion; Female; Humans; Hyperthermia, Induced; Intestinal Fistula; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Postoperative Complications; Postoperative Hemorrhage; Pseudomyxoma Peritonei; Retrospective Studies; Risk Factors; Young Adult

2020